FinancialContent is the trusted provider of stock market information to the media industry.
Galena Receives Patent
Posted on July 18, 2012 at 20:13 PM EDT
The U. S. Patent and Trademark Office issued a patent Galena Biopharma Inc. (Nasdaq: GALE) for its NeuVax breast cancer vaccine lifting the stock price 28 cents to close at $1.99.


Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
   
Financial Widgets

Display market data, financial news or stock quotes - Learn More

Advertising Network

Advertise on FinancialContent's huge network - Learn More

Web Services

Power your internet and wireless applications - Learn More